Lenalidomide for lupus erythematosus, cutaneous

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Trial registered. A trial in people is registered. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 11 May 2025: Trial registered, NCT06965244

The trials

NCT06965244: Lenalidomide vs Methotrexate in Difficult-to-treat Cutaneous Lupus Erythematosus

State
Not started
Phase
Phase 3
People
122 planned
Started
1 Oct 2025
Primary completion
1 Feb 2029
Arms
Lenalidomide with aspirin
Results
None posted
  1. 11 May 2025: Trial registered

How the status changed

  1. 19 Nov 2026: First set: Trial registered

About the treatment

Kind of treatment: Drug.

Also known as Revlimid.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.